1. Home
  2. MFG vs BMY Comparison

MFG vs BMY Comparison

Compare MFG & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mizuho Financial Group Inc. Sponosred ADR (Japan)

MFG

Mizuho Financial Group Inc. Sponosred ADR (Japan)

SELL

Current Price

$9.83

Market Cap

113.5B

Sector

Finance

ML Signal

SELL

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

SELL

Current Price

$61.29

Market Cap

127.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MFG
BMY
Founded
2003
1887
Country
Japan
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
113.5B
127.0B
IPO Year
2005
2006

Fundamental Metrics

Financial Performance
Metric
MFG
BMY
Price
$9.83
$61.29
Analyst Decision
Buy
Hold
Analyst Count
2
28
Target Price
$11.64
★ $65.25
AVG Volume (30 Days)
4.5M
★ 9.2M
Earning Date
11-13-2026
10-29-2026
Dividend Yield
0.72%
★ 4.11%
EPS Growth
N/A
★ 178.46
EPS
N/A
★ 3.98
Revenue
N/A
★ $48,194,000,000.00
Revenue This Year
$104.46
$4.23
Revenue Next Year
$12.54
N/A
P/E Ratio
$16.74
★ $15.42
Revenue Growth
★ N/A
N/A
52 Week Low
$6.45
$45.27
52 Week High
$11.49
$68.64

Technical Indicators

Market Signals
Indicator
MFG
BMY
Relative Strength Index (RSI) 44.67 45.29
Support Level $9.60 $59.94
Resistance Level $9.93 $63.47
Average True Range (ATR) 0.21 1.72
MACD 0.08 -0.03
Stochastic Oscillator 52.12 18.05

Price Performance

Historical Comparison
MFG
BMY

About MFG Mizuho Financial Group Inc. Sponosred ADR (Japan)

Mizuho Financial Group is roughly tied with megabank peer Sumitomo Mitsui Financial Group for the status as Japan's second-largest bank after Mitsubishi UFJ Financial Group. In Japan, Mizuho has more of a corporate focus than SMFG, which has a larger retail business. Its overseas weighting is slightly smaller than that of MUFG. Mizuho expanded in recent years beyond its traditional Japanese borrowers, mainly through its core banking and securities units, focusing on the financing needs of global multinational corporations.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: